Everolimus in patients with metastatic renal cell carcinoma (RCC) previously treated with bevacizumab: Final results of prospective multicenter study.

Anton Snegovoy,Sergey Varlamov,Sufia Safina,Ilya Varlamov,Ludmila Gurina,Liudmila V. Manzyuk,Ilya Tsimafeyeu

Everolimus in patients with metastatic renal cell carcinoma (RCC) previously treated with bevacizumab: Final results of prospective multicenter study.

2015

Anton Snegovoy
Sergey Varlamov
Sufia Safina
Ilya Varlamov
Ludmila Gurina
Liudmila V. Manzyuk
Ilya Tsimafeyeu

e15621 Background: Everolimus provides a consistent clinical benefit in the treatment of patients with metastatic RCC who progressed on previous TKI treatment. The aim of this study is to evaluate ...

Keywords:

Bevacizumab
Oncology
Pathology
Everolimus
Renal cell carcinoma
Internal medicine
Medicine
previously treated
multicenter study
in patient

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations